Sean P. Mahabir

1.6k total citations
65 papers, 1.1k citations indexed

About

Sean P. Mahabir is a scholar working on Infectious Diseases, Parasitology and Insect Science. According to data from OpenAlex, Sean P. Mahabir has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 40 papers in Parasitology and 15 papers in Insect Science. Recurrent topics in Sean P. Mahabir's work include Dermatological diseases and infestations (28 papers), Vector-borne infectious diseases (27 papers) and Insect and Pesticide Research (12 papers). Sean P. Mahabir is often cited by papers focused on Dermatological diseases and infestations (28 papers), Vector-borne infectious diseases (27 papers) and Insect and Pesticide Research (12 papers). Sean P. Mahabir collaborates with scholars based in United States, South Africa and Hungary. Sean P. Mahabir's co-authors include Robert H. Six, Csilla Becskei, Rodney R. Walters, David E. Capen, Jessica J. Rykken, Tom L. McTier, Robert B. McCall, Josephus Fourie, Kelly F. Walsh and Gina Μ. Michels and has published in prestigious journals such as Conservation Biology, Journal of Environmental Management and Drug Metabolism and Disposition.

In The Last Decade

Sean P. Mahabir

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sean P. Mahabir United States	20	474	455	235	222	183	65	1.1k
Edward Mitre United States	26	498 1.1×	640 1.4×	89 0.4×	70 0.3×	118 0.6×	63	1.7k
Yuwaporn Sakolvaree Thailand	17	217 0.5×	259 0.6×	34 0.1×	229 1.0×	151 0.8×	38	1.0k
Ayşegül Taylan Özkan Türkiye	18	410 0.9×	528 1.2×	37 0.2×	111 0.5×	43 0.2×	114	1.1k
Carmen Cuéllar Spain	23	185 0.4×	804 1.8×	37 0.2×	45 0.2×	109 0.6×	106	1.5k
Martha Brown United States	18	188 0.4×	90 0.2×	66 0.3×	35 0.2×	60 0.3×	31	1.3k
Stephen A. Estes United States	17	626 1.3×	169 0.4×	94 0.4×	109 0.5×	96 0.5×	27	916
Leonardo Puerta Colombia	19	91 0.2×	137 0.3×	236 1.0×	173 0.8×	41 0.2×	57	1.2k
R.J. Shaw New Zealand	25	108 0.2×	323 0.7×	49 0.2×	45 0.2×	590 3.2×	54	1.6k
John Asiedu Larbi Ghana	11	498 1.1×	379 0.8×	20 0.1×	183 0.8×	29 0.2×	43	1.0k
Ernesto Akio Taketomi Brazil	19	88 0.2×	212 0.5×	239 1.0×	21 0.1×	75 0.4×	62	966

Countries citing papers authored by Sean P. Mahabir

Since Specialization

Citations

This map shows the geographic impact of Sean P. Mahabir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean P. Mahabir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean P. Mahabir more than expected).

Fields of papers citing papers by Sean P. Mahabir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean P. Mahabir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean P. Mahabir. The network helps show where Sean P. Mahabir may publish in the future.

Co-authorship network of co-authors of Sean P. Mahabir

This figure shows the co-authorship network connecting the top 25 collaborators of Sean P. Mahabir. A scholar is included among the top collaborators of Sean P. Mahabir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean P. Mahabir. Sean P. Mahabir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mahabir, Sean P., et al.. (2024). Evaluation of the efficacy of Simparica Trio® in the prevention of the transmission of Babesia canis by infected Dermacentor reticulatus to dogs. Parasites & Vectors. 17(1). 51–51. 1 indexed citations

Geurden, Thomas, et al.. (2023). Insecticidal activity of Simparica and Simparica Trio against Aedes aegypti in dogs. Parasites & Vectors. 16(1). 95–95. 3 indexed citations

Walters, Rodney R., Vickie L. King, Sean P. Mahabir, et al.. (2023). Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs. Veterinary Immunology and Immunopathology. 258. 110574–110574. 8 indexed citations

Malpas, Phyllis B., Sean P. Mahabir, Joseph F. Boucher, et al.. (2023). Safety of Simparica Trio® (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs. Parasites & Vectors. 16(1). 119–119.

McCall, John W., et al.. (2022). Preventive efficacy of six monthly oral doses of Simparica Trio®, Heartgard® Plus, and Interceptor® Plus against a macrocyclic lactone-resistant strain (ZoeLA) of heartworm (Dirofilaria immitis) in dogs. Parasites & Vectors. 15(1). 81–81. 3 indexed citations

Hainsworth, Emma, et al.. (2022). How can we recruit more men of African or African-Caribbean ancestry into our research? Co-creating a video to raise awareness of prostate cancer risk and the PROFILE study. Research Involvement and Engagement. 8(1). 14–14. 5 indexed citations

Becskei, Csilla, et al.. (2020). Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasites & Vectors. 13(1). 72–72. 11 indexed citations

Becskei, Csilla, et al.. (2020). Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients. Parasites & Vectors. 13(1). 385–385. 9 indexed citations

Becskei, Csilla, et al.. (2020). Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA. Parasites & Vectors. 13(1). 70–70. 8 indexed citations

10.

Bowman, Dwight D., et al.. (2017). Evaluation of the efficacy of ProHeart® 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs. Parasites & Vectors. 10(S2). 502–502. 18 indexed citations

11.

Moyaert, Hilde, et al.. (2017). A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client‐owned dogs with atopic dermatitis. Veterinary Dermatology. 28(6). 593–593. 71 indexed citations

12.

Six, Robert H., et al.. (2016). Comparative speed of kill of sarolaner (Simparica™) and afoxolaner (NexGard®) against induced infestations of Ctenocephalides felis on dogs. Parasites & Vectors. 9(1). 90–90. 7 indexed citations

13.

Six, Robert H., et al.. (2016). Comparative speed of kill of sarolaner (Simparica™) and fluralaner (Bravecto®) against induced infestations of Ctenocephalides felis on dogs. Parasites & Vectors. 9(1). 92–92. 7 indexed citations

14.

Six, Robert H., et al.. (2016). Comparative speed of kill of sarolaner (Simparica™) and spinosad plus milbemycin oxime (Trifexis®) against induced infestations of Ctenocephalides felis on dogs. Parasites & Vectors. 9(1). 93–93. 5 indexed citations

15.

Six, Robert H., et al.. (2016). Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto®) against induced infestations of Amblyomma americanum on dogs. Parasites & Vectors. 9(1). 399–399. 6 indexed citations

16.

Six, Robert H., et al.. (2016). Comparative speed of kill of sarolaner (Simparica™) and afoxolaner (NexGard®) against induced infestations of Rhipicephalus sanguineus s.l. on dogs. Parasites & Vectors. 9(1). 91–91. 6 indexed citations

17.

Geurden, Thomas, Csilla Becskei, Christina Strübe, et al.. (2016). Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe. Veterinary Parasitology. 222. 33–36. 22 indexed citations

18.

Six, Robert H., et al.. (2016). Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs. Veterinary Parasitology. 222. 23–27. 15 indexed citations

19.

Mahabir, Sean P., Stijn Casaert, Nathalie De Wilde, et al.. (2012). Assessing resistance against macrocyclic lactones in gastro-intestinal nematodes in cattle using the faecal egg count reduction test and the controlled efficacy test. Veterinary Parasitology. 189(2-4). 378–382. 28 indexed citations

20.

Hickman, M. Anne, et al.. (2008). Safety, pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (Cerenia^TM) for the prevention of emesis and motion sickness in cats. Journal of Veterinary Pharmacology and Therapeutics. 31(3). 220–229. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact